Method of constructing heart failure model animal

Details Method of constructing heart failure model animal Method of constructing heart failure model animal

2007-01-23

2007-01-23

Nguyen, Dave Trong (Department: 1632)

Multicellular living organisms and unmodified parts thereof and

Nonhuman animal

The nonhuman animal is a model for human disease

C800S003000

Reexamination Certificate

active

10380920

ABSTRACT:
A non-human mammal which is usefully and effectively applicable to the screening of a substance to be employed for preventing and treating heart failure. This animal is an animal model of heart failure prepared by starting both coronary stenosis and the stenosis of arteries other than the coronary artery and the abdominal artery of a non-human mammal within the same period of time.

REFERENCES:
Meggs LG, Coronary artery stenosis in rats affects beta-adrenergic receptor signalling in myocytes, 1997, Cardiovascular Res. vol. 33, pp. 98-109.
Anthonio RL, Myocardial infarction and aortic banding, 1997, Japan Heart Journal, vol. 38, pp. 697-708.
Bing OH, Studies of prevention, treatment and mechanisms of heart failure in the aging spontaneously hypertensive rat, 2002, vol. 7, pp. 71-88.
Galinanes M, Impaired Cardioplegic Delivery and the Loss of Cardioprotection: a Role for Preconditioning, 1997, J. Mol. Cell Cardiol., vol. 29, pp. 849-854.
J.M. Power, et al., “Large Animal Models of Heart Failure”, Australian and New Zealand Journal of Medicine, (1999), pp. 395-402, vol. 29, No. 3, XP008030977.
K. Hashimoto, et al., “Positive Inotropic Effect of 3,4-Dihydro-6-[4-(3,4-dimethoxybenzoyl)-1-piperazinyl]-2(1H)-quinolinone (OPC-8212) in the Dog with Experimentally-induced Right-sided Heart Failure”, Arzneimittel-Forschung/Drug Research, (1984), pp. 390-393, 34/3, XP008039188, Figure 1.
K. Kusumoto, et al., “In vitro and in vivo Pharmacology of a Non-acylguanidine Na-H Exchange Inhibitor, T-162559”, Journal of Molecular and Cellular Cardiology, (2001), pp. A64, vol. 33, No. 6, XP002306982—abstract.
Anthonio, et al. “Myocardial Infarction with Aortic Banding A Combined Rat Model of Heart Failure” University of Groningen, The Netherlands. pp. 697-7088 (Feb. 26, 1997k).
Turcano, et al. “Minoxidil accelerates heart failure development in rats with ascending aortic constriction” Can. J. Physiol. Pharmacol 76: 613-620 (1998)).
Linz, et al. “Ace Inhibition Decreases Postoperative Mortality in Rats with Left Ventricular Hypertrophy and Myocardial Infarction” Clin. and Exper. Hypertension 18(5) :691-712 (1996).
Nolan, et al. “Increased Afterload Aggravates Infarct Expansion After Acute Myocardial Infarction” JACC 12(5): 1318-1325 (Nov. 1988).
Takechi, et al. “Recovery of Cardiac Norepinephrine Concentration and Tyrosine Hydroxylase Activity by the Central α2-Adrenoceptor Agonist Guanabenz in Rats with Aortic Constriction” Journal of Cardiovascular Pharmacology 33:409-413 (1999).

Affiliated with

Also associated with

Rating

Method of constructing heart failure model animal does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method of constructing heart failure model animal, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of constructing heart failure model animal will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3810423